HomeBUSINESS
BUSINESS

Chugai Sues Daiichi Sankyo, Pfizer over Herceptin Biosimilars
(Oct.15.2018)

Chugai Pharmaceutical has filed patent infringement suits against Daiichi Sankyo and Pfizer Japan, seeking to block the launch of their biosimilar versions of its anti-HER2 monoclonal antibody Herceptin (trastuzumab) ...
(LOG IN FOR FULL STORY)